Clinical Trials Browser

Completed × Interventional × Capsules × Clear all

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04336124 2022-11-28

Safety and Pharmacokinetic Study of CVM-1118 Extended-Release in Advanced Cancer Patients

Phase 1 Completed

5 enrolled

Tumor-Agnostic

Neoplasms

NCT04727138 2022-05-16

3-part Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EXS21546

Phase 1 Completed

64 enrolled

Tumor-Agnostic

Neoplasms

NCT03469310 2021-05-11

Minimizing Narcotic Analgesics After Endocrine Surgery

Phase 4 Completed

126 enrolled

Head & Neck

Agnosia, Goiter, Opioid-Related Disorders, Parathyroid Diseases, Parathyroid Neoplasms, Thyroid Diseases, Thyroid Neoplasms, Thyroid Nodule

NCT01149720 2019-02-12

Determination of the Relative Bioavailability of ARQ 197 Tablet Formulation With Capsule C Formulation as a Reference in Subjects With Advanced Solid Tumors

Phase 1 Completed

24 enrolled

Other solid neoplasm

Solid Tumors

NCT02536391 2016-11-02

Ipatasertib (GDC-0068) Study to Evaluate Formulation Change and Food Effect on Bioavailability in Healthy Subjects

Phase 1 Completed

18 enrolled

Tumor-Agnostic

Neoplasms

NCT00390806 2014-01-20

Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer

Phase 3 Completed

472 enrolled 35 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00698516 2012-03-27

Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer

Phase 2 Completed

50 enrolled 13 charts

Thoracic

Small Cell Lung Carcinoma

Clinical Trials

FluBuBe

Safety and Pharmacokinetic Study of CVM-1118 Extended-Release in Advanced Cancer Patients

3-part Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EXS21546

Minimizing Narcotic Analgesics After Endocrine Surgery

Determination of the Relative Bioavailability of ARQ 197 Tablet Formulation With Capsule C Formulation as a Reference in Subjects With Advanced Solid Tumors

Ipatasertib (GDC-0068) Study to Evaluate Formulation Change and Food Effect on Bioavailability in Healthy Subjects

Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer

Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer